Resumen
Cellular metabolism represents a newly identified checkpoint of effector functions in the immune system. A solid body of work has characterized the metabolic requirements of normal T cells during activation and differentiation into polarized effector subsets. Similar studies have been initiated to characterize the metabolic requirements for B cells and myeloid cells. Only a few studies though have characterized the metabolism of immune cells in the context of autoimmune diseases. Here, we review what is known on the altered metabolic patterns of CD4+ T cells, B cells, and myeloid cells in lupus patients and lupus-prone mice and how they contribute to lupus pathogenesis. We also discuss how defects in immune metabolism in lupus can be targeted therapeutically.
Idioma original | English (US) |
---|---|
Número de artículo | 66 |
Publicación | Current rheumatology reports |
Volumen | 18 |
N.º | 11 |
DOI | |
Estado | Published - nov 1 2016 |
Publicado de forma externa | Sí |
ASJC Scopus subject areas
- Rheumatology